( a - d ) Observed data for participants in the full analysis set treated with semaglutide 2.4 mg (a, c) or placebo (b, d) during the in-trial period
Even if your b12 level up
The strongest evidence categories are: Skin aging and cosmetic improvement : Multiple topical trials over 8 to 16 weeks have shown improvements in elasticity, wrinkles, and pigmentation
After 17 weeks off treatment or placebo, 13.7% of the placebo group had advanced to type 2 diabetes, compared to just 2.4% of the group whod received tirzepatide
In adipose (fat) tissue, GIP receptor activation appears to improve lipid buffering capacity and insulin sensitivity, which helps mitigate some of the gastrointestinal side effects typically caused by pure GLP-1 stimulation
Understanding your genetic predispositions may provide context for expected response trajectories